Eli Lilly and Co (LLY)
818.93
-10.81
(-1.30%)
USD |
NYSE |
Nov 01, 16:00
816.48
-2.45
(-0.30%)
After-Hours: 20:00
Eli Lilly Total Liabilities (Quarterly): 61.29B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.29B |
| June 30, 2024 | 58.24B |
| March 31, 2024 | 51.05B |
| December 31, 2023 | 53.14B |
| September 30, 2023 | 46.61B |
| June 30, 2023 | 43.66B |
| March 31, 2023 | 41.87B |
| December 31, 2022 | 38.71B |
| September 30, 2022 | 37.30B |
| June 30, 2022 | 38.40B |
| March 31, 2022 | 37.46B |
| December 31, 2021 | 39.65B |
| September 30, 2021 | 40.23B |
| June 30, 2021 | 41.15B |
| March 31, 2021 | 39.74B |
| December 31, 2020 | 40.81B |
| September 30, 2020 | 38.95B |
| June 30, 2020 | 37.70B |
| March 31, 2020 | 37.91B |
| December 31, 2019 | 36.59B |
| September 30, 2019 | 34.43B |
| June 30, 2019 | 35.81B |
| March 31, 2019 | 35.44B |
| December 31, 2018 | 33.00B |
| September 30, 2018 | 30.47B |
| Date | Value |
|---|---|
| June 30, 2018 | 30.74B |
| March 31, 2018 | 29.77B |
| December 31, 2017 | 33.31B |
| September 30, 2017 | 28.05B |
| June 30, 2017 | 26.78B |
| March 31, 2017 | 23.52B |
| December 31, 2016 | 24.73B |
| September 30, 2016 | 21.97B |
| June 30, 2016 | 21.82B |
| March 31, 2016 | 19.66B |
| December 31, 2015 | 20.98B |
| September 30, 2015 | 21.06B |
| June 30, 2015 | 21.33B |
| March 31, 2015 | 20.71B |
| December 31, 2014 | 20.92B |
| September 30, 2014 | 16.97B |
| June 30, 2014 | 17.02B |
| March 31, 2014 | 16.41B |
| December 31, 2013 | 17.61B |
| September 30, 2013 | 17.07B |
| June 30, 2013 | 17.99B |
| March 31, 2013 | 17.34B |
| December 31, 2012 | 19.62B |
| September 30, 2012 | 18.26B |
| June 30, 2012 | 17.50B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
36.59B
Minimum
Dec 2019
61.29B
Maximum
Sep 2024
43.02B
Average
39.99B
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Johnson & Johnson | 108.13B |
| Merck & Co Inc | 68.98B |
| Viking Therapeutics Inc | 26.44M |
| Moderna Inc | 3.968B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 75.61B |
| Shareholders Equity (Quarterly) | 14.24B |
| Debt to Equity Ratio | 2.185 |
| Current Ratio | 1.273 |
| Net Debt Paydown Yield | -0.31% |